Latest News and Press Releases

Oslo, Norway, 25 April 2025 Please find attached the Annual Report for 2024 for Vistin Pharma ASA (VISTN). There are no material changes in the financial statements compared to the preliminary full...

Oslo, Norway, 25th of April 2025 Vistin Pharma ASA (VISTN) today announces the financial results for the first quarter of 2025. Revenue in the first quarter ended at MNOK 115 compared to MNOK 104 in...

Oslo, Norway, 15 April 2025 Vistin Pharma ASA (VISTN) will release its first quarter results on Friday 25th of April 2025. Vistin Pharma will host a conference call for all shareholders and...

The Board of Directors of Vistin Pharma ASA (VISTN) will propose to distribute a cash dividend of total NOK 1.25 per share, to be paid in June, for the accounting year of 2024. The formal decision...

Oslo, Norway, 13th of February 2025 Vistin Pharma ASA (VISTN) today announces the financial results for the fourth quarter and preliminary results of 2024. Revenue in the fourth quarter ended at...

Oslo, Norway, 6 February 2025 Vistin Pharma ASA will release its fourth quarter and preliminary 2024 results on Thursday 13th of February 2025. Vistin Pharma will host a conference call for all...

The shares in Vistin Pharma ASA will be traded ex dividend NOK 0.50 as from today, 06.11.2024. ...

Oslo, Norway, 31st of October 2024 Vistin Pharma ASA (VISTN) today announces the financial results for the third quarter of 2024. Revenue in the third quarter ended at MNOK 106 compared to MNOK...

Oslo, Norway, 24 October 2024 Vistin Pharma ASA will release its third quarter and YTD 2024 results on Thursday 31st of October 2024. Vistin Pharma will host a conference call for all shareholders...

Please find attached the first half 2024 financial report including the Responsibility Statement. ***** For further information, please contact: Alexander KarlsenCFO+47 97 05 36...